# Glucose Control During Glucocorticoid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

> **NCT02253121** · PHASE4 · COMPLETED · sponsor: **Slotervaart Hospital** · enrollment: 46 (actual)

## Conditions studied

- Hyperglycemia Steroid-induced

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Sliding scale insulin

## Key facts

- **NCT ID:** NCT02253121
- **Lead sponsor:** Slotervaart Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-03
- **Final completion:** 2017-05
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2018-05-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02253121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02253121, "Glucose Control During Glucocorticoid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02253121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*